Sangamo Therapeutics
SGMO
SGMO
145 hedge funds and large institutions have $869M invested in Sangamo Therapeutics in 2014 Q1 according to their latest regulatory filings, with 39 funds opening new positions, 51 increasing their positions, 39 reducing their positions, and 9 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
145
Holders Change
+30
Holders Change %
+26.09%
% of All Funds
4.19%
Holding in Top 10
3
Holding in Top 10 Change
-2
Holding in Top 10 Change %
-40%
% of All Funds
0.09%
New
39
Increased
51
Reduced
39
Closed
9
Calls
$250M
Puts
$25.4M
Net Calls
+$225M
Net Calls Change
+$142M
Top Buyers
| 1 |
Fidelity Investments
Boston,
Massachusetts
|
+$32.9M |
| 2 |
FCM
Frontier Capital Management
Boston,
Massachusetts
|
+$23.8M |
| 3 |
Franklin Resources
San Mateo,
California
|
+$19.8M |
| 4 |
Invesco
Atlanta,
Georgia
|
+$14.8M |
| 5 |
PA
Perceptive Advisors
New York
|
+$14.5M |
Top Sellers
| 1 |
AWMDMG
Austin W. Marxe & David M. Greenhouse
New York
|
-$22.5M |
| 2 |
Goldman Sachs
New York
|
-$20.3M |
| 3 |
PCA
Private Capital Advisors
Darien,
Connecticut
|
-$14.7M |
| 4 |
Adage Capital Partners
Boston,
Massachusetts
|
-$13.6M |
| 5 |
SCA
SAC Capital Advisors
Stamford,
Connecticut
|
-$11.1M |
